Related Experiment Video
Updated: Oct 8, 2025

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Relationship Between Myocardial Injury During Index Hospitalization for SARS-CoV-2 Infection and Longer-Term Outcomes
Brittany Weber1, Hasan Siddiqi1, Guohai Zhou2
1Division of Cardiovascular Medicine Department of Medicine, Heart and Vascular Center Brigham and Women's Hospital Harvard Medical School Boston MA.
Insights
Myocardial injury during COVID-19 hospitalization, indicated by elevated troponin levels, is linked to higher mortality and predicts long-term health issues. Survivors of this injury face a low incremental mortality risk within 12 months.
Area of Science:
- Cardiology
- Infectious Diseases
- Pulmonology
Background:
- Myocardial injury during COVID-19 hospitalization correlates with increased mortality.
- The long-term sequelae of SARS-CoV-2 infection, particularly concerning cardiac health, remain largely unknown.
- This study investigates the association between myocardial injury in COVID-19 patients and their subsequent long-term health outcomes.
Purpose of the Study:
- To assess the relationship between myocardial injury, defined by high-sensitivity cardiac troponin T levels, during COVID-19 hospitalization and longer-term outcomes.
- To identify predictors of post-acute sequelae of COVID-19 (PACS).
Main Methods:
- A prospective cohort study included 483 patients hospitalized with SARS-CoV-2 between March and May 2020.
- Cardiac biomarkers, including high-sensitivity cardiac troponin T, were systematically collected.
- Outcomes such as mortality, thrombotic and cardiovascular complications, readmissions, and PACS symptoms were adjudicated and stratified based on myocardial injury status.
Main Results:
- During index hospitalization, 301 (62.3%) patients experienced cardiac injury (hs-cTnT ≧14 ng/L).
- Mortality rates at 12 months were significantly higher for patients with cardiac injury (33.2%) compared to those with low-level positive troponin (4.9%) or undetectable troponin (0%).
- Among survivors, 24% required readmission within 12 months, and 37% reported ongoing COVID-19 symptoms, 16.1% neurocognitive decline, and 19.9% worsening functional status at 6-month follow-up.
Conclusions:
- Myocardial injury during COVID-19 hospitalization is associated with increased mortality and may predict the likelihood of developing post-acute sequelae of COVID-19.
- For patients who survive the initial hospitalization, the risk of death within 12 months is low, even if they had elevated troponin levels.
- Elevated troponin T levels during acute COVID-19 illness serve as a critical indicator for long-term adverse outcomes and potential post-COVID conditions.
Abstract:
Background Myocardial injury in patients with COVID-19 is associated with increased mortality during index hospitalization; however, the relationship to long-term sequelae of SARS-CoV-2 is unknown. This study assessed the relationship between myocardial injury (high-sensitivity cardiac troponin T level) during index hospitalization for COVID-19 and longer-term outcomes. Methods and Results This is a prospective cohort of patients who were hospitalized at a single center between March and May 2020 with SARS-CoV-2. Cardiac biomarkers were systematically collected. Outcomes were adjudicated and stratified on the basis of myocardial injury. The study cohort includes 483 patients who had high-sensitivity cardiac troponin T data during their index hospitalization. During index hospitalization, 91 (18.8%) died, 70 (14.4%) had thrombotic complications, and 126 (25.6%) had cardiovascular complications. By 12 months, 107 (22.2%) died. During index hospitalization, 301 (62.3%) had cardiac injury (high-sensitivity cardiac troponin T≧14 ng/L); these patients had 28.6%, 32.2%, and 33.2% mortality during index hospitalization, at 6 months, and at 12 months, respectively, compared with 4.1%, 4.9%, and 4.9% mortality for those with low-level positive troponin and 0%, 0%, and 0% for those with undetectable troponin. Of 392 (81.2%) patients who survived the index hospitalization, 94 (24%) had at least 1 readmission within 12 months, of whom 61 (65%) had myocardial injury during the index hospitalization. Of 377 (96%) patients who were alive and had follow-up after the index hospitalization, 211 (56%) patients had a documented, detailed clinical assessment at 6 months. A total of 78 of 211 (37.0%) had ongoing COVID-19-related symptoms; 34 of 211 (16.1%) had neurocognitive decline, 8 of 211 (3.8%) had increased supplemental oxygen requirements, and 42 of 211 (19.9%) had worsening functional status. Conclusions Myocardial injury during index hospitalization for COVID-19 was associated with increased mortality and may predict who are more likely to have postacute sequelae of COVID-19. Among patients who survived their index hospitalization, the incremental mortality through 12 months was low, even among troponin-positive patients.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis III: Medical Management
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis IV: Nursing Management

